Variable reactivity of monoclonal antibodies (MAB) against the X-hapten indicates structural differences in the X-determinant expressed on Hodgkin's (HD) and other cell lines: Effect of neuraminidase treatment (NT)

E. Paietta, P. H. Wiernik

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)No. 1157
JournalProceedings of the American Association for Cancer Research
VolumeVOL. 26
StatePublished - Jan 1 1985

ASJC Scopus subject areas

  • Medicine(all)

Cite this